Phytochemicals as Lead Compounds for New DrugDiscovery presents complete coverage of the recent advances in the discovery of phytochemicals from medicinal plants as models to the development of new drugs and chemical entities. Functional bioactive compounds of plant origin have been an invaluable source for many human therapeutic drugs and have played a major role in the treatment of diseases around the world. These compounds possess enormous structural and chemical diversity and have led to many important discoveries. This book presents fundament concepts and factors affecting the choice for plant-based products, as well as recent advances in computer-aided drug discovery and FDA drug candidacy acceptance criteria. It also details the various bioactive lead compounds and molecular targets for a range of life-threatening diseases including cancer, diabetes, and neurodegenerative diseases.
Written by a global team of experts, Phytochemicals as Lead Compounds for New Drug Discovery is an ideal resource for drug developers, phytochemists, plant biochemists, food and medicinal chemists, nutritionists and toxicologists, chemical ecologists, taxonomists, analytical chemists, and other researchers in those fields. It will also be very valuable to professors, students, and researchers in this domain.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Part I: Plants As Natural Sources Of Drugs 1. Plant Secondary Metabolites as Lead Compounds for the Production of Potent Drugs 2. Factors Affecting the Choice for Plant-based Products in Drug Discoveries 3. Advances in Computer-Aided Drug Discovery 4. FDA drug candidacy acceptance criteria and steps: Problems and way forward
Part II: Bio-functional Leads for Drug Development 5. Bioactive lead compounds and molecular targets for the treatment of heart diseases 6. Natural bioactive lead compounds effective against haematological malignancies 7. Adjunct Therapeutic Potential of Phytochemicals Against Cancer 8. Anti-diabetic lead compounds and targets for drug development 9. Anti-obesity functional leads and targets for drug development 10. Phytochemicals as therapeutic interventions in neurodegenerative diseases 11. Organosulfur phytochemicals against metabolic and neurodegenerative diseases: Benefits and risks 12. Lead compounds with the potentials for the treatment of chronic liver diseases 13. Phytocompounds and potential target sites against skin diseases 14. Phytochemicals as emerging therapeutic agents for alopecia treatment 15. Antiviral phytocompounds for drug development: A data mining studies 16. Shikimic acid as intermediary model for the production of drugs effective against influenza virus 17. Antimicrobial Lead Compounds from Marine Plants 18. Antibacterial lead compounds and targets for drug development 19. Awareness and Current Therapeutic Strategies of Malaria 20. Bioactive lead compounds and targets for the development of anti-malarial drugs 21. Bioactive lead compounds and targets for the development of anti-inflammatory drugs 22. Functional lead compounds and targets for the development of drugs for the treatment of male infertility 23. Prenylated flavonoids as a promising drug discovery candidate: A pharmacological update
Authors
Chukwuebuka Egbuna chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom)..
Chukwuebuka Egbuna is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. Egbuna has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited over 20 books with Elsevier, Springer, Wiley and Taylor & Francis. His most recent book is his 3 volume book on Coronavirus Drug Discovery published by Elsevier. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services. He is a reviewer and editorial board member of various journals. His primary research interests cut across biochemistry, phytochemistry, pharmacology, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.
Shashank Kumar Center for Biochemistry and Microbial Sciences, Central University of Punjab, Bathinda, India.
Shashank Kumar, PhD, obtained his BSc, MSc, and PhD degrees in biochemistry from the University of Allahabad. He has worked as a postdoctoral fellow at the Department of Biochemistry in King George's Medical University. Dr. Kumar has about 60 published scientific papers, reviews, editorial articles, and book chapters in various national and international peer-reviewed journals and has been cited more than 1,200 times. His expertise is in the areas of free radical biology, cancer biology, characterization of plant products, xenobiotic metabolism, and microbiology. He is familiar with many biochemical techniques such as spectrophotometry, ELISA, electrophoresis, PCR, RT-PCR, flow cytometry, TLC, HPLC, LC-MS, cell culture, and microbiological techniques. He has presented his research findings at more than 25 national and international conferences and has attended about 30 workshops at many major universities and medical colleges throughout the India. Dr. Kumar is a life-time member of the Italo-Latin American Society of Ethnomedicine and the Indian Sciences Congress Association, and a member of the Asian Council of Science Editors in Dubai and Publication Integrity & Ethics in London. He has been awarded junior, senior, and research associate fellowships formulated and funded by various Indian agencies, such as the Indian Council of Medical Research, University Grants Commission, and the Council of Scientific and Industrial Research India.
Jonathan C. Ifemeje Associate Professor, Department of Biochemistry, Faculty of Natural Sciences, Chukwuemeka Odumegwu Ojukwu University, Nigeria.
Dr. Jonathan Chinenye Ifemeje, PhD, is an Associate Professor (Reader) in the Department of Biochemistry, Faculty of Natural Sciences, Chukwuemeka Odumegwu Ojukwu University, Nigeria. He has published over 40 articles with international publishers and has attended series of workshops and conferences. He has also served as an external examiner for various institutions. He is the managing editor of the Tropical Journal of Applied Natural Sciences and a reviewer and an editorial board member for various reputable journals. He has worked extensively in the areas of phytochemistry, environment, and nutritional toxicology. He is a member of various institutes, including the Institute of Chartered Chemists of Nigeria, the Nigerian Society of Biochemistry and Molecular Biology, and Society of Quality Assurance. Dr. Ifemeje is presently the Director of Student Industrial Work Experience Scheme (SIWES), COOU and the Department of Biochemistry Postgraduate Coordinator, COOU. He has also served as the department and faculty staff adviser. He obtained his PhD in applied biochemistry from Nnamdi Azikiwe University, Awka, Nigeria, and his MSc degree in nutrition and toxicology from the University of Port-Harcourt, Nigeria.
Shahira M. Ezzat Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Egypt.
Professor Shahira M. Ezzat holds a Ph.D in pharmacognosy from the College of Pharmacy, Cairo University (CU) since 2007. She is a frequent speaker in conferences around the world, in which she won several prizes for excellent presentations. She has published over 60 articles including research articles, reviews, books, and book chapters in the field of chemistry and biological activity of natural products. She is positioned as a professor and head of Department of Pharmacognosy, College of Pharmacy, MSA University, Egypt. Her main field of research includes the isolation of bioactive plant constituents using advanced chromatographic techniques and the elucidation of their structures using different chemical and spectral methods. She has also performed work using in vitro enzymes-based assays for biological evaluation of plant extracts and the standardization of biologically active extracts using HPLC and other advanced techniques. In addition to identification of chemical constituents in plant extracts using HPLC-MS/MS and UPLC-MS/MS, Professor Ezzat currently works on the deep mechanism of anticancer activity of pure compounds in collaboration with National Cancer Institute (NCI) and searches for the effectiveness of Egyptian herbs as antiaging agents.
Saravanan Kaliyaperumal Department of Zoology, Nehru Memorial College, Tamil Nadu, India.
Dr. Saravanan Kaliyaperumal has been engaged in teaching and research for over 16 years. He obtained MSc Wildlife Biology and PhD degrees at A.V.C. College, Mayiladuthurai, and obtained his MSc, Bioinformatics degree at Annamalai University, India. He has been awarded Har Gobind Kohorana Best Scientist Award (2016-17). He has published 55 research papers and a book and has contributed chapters to four other books. He has completed one major research project and has organized one national and two international conferences, as well as three state-level workshops. He has been engaged in a number of academic roles at Nehru Memorial College, including his most recent appointment as Dean of Academic Affairs. He is a reviewer and editorial board member of various journals. He is a member of Indian Society of Systems for Science and Engineering and OISCA-International in Tokyo, Japan.
